IOL Chemicals & Pharmaceuticals Ltd has received approval of Korean Ministry of Food and Drug Safety (Korean FDA) for Company’s Pharmaceuticals API products ‘IBUPROFEN and ‘FENOFIBRATE’. The approval of Korean FDA re-establishes the Company’s efforts to…
IOL Chemicals & Pharmaceuticals Ltd receives Korean FDA approval – Equity Bulls
Share this article
More News


Technical Analysis on One ASX-Listed Materials Stock – G6M
August 13, 2026

UK regulator, crypto exchange HTX locked in settlement talks
August 13, 2026


